Radical Prostatectomy and Perioperative Fluid Therapy
Phase 4
18 Years
80 Years
18 Years
80 Years
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
Radical Prostatectomy and Perioperative Fluid Therapy
Inclusion Criteria:
- Patients with cancer in there prostate
Exclusion Criteria:
- Patients who don't understand the information
- ASA > III
- Patients that are under treatment with the drug triazolam
- Patients with af known renal decease
- Patients with a psychiatric decease
- Alcohol abuse
- Severe haemorrhagic decease
- Cancer in the mouth,pharynx, larynx or oesophagus
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
To investigate orthostatic cardiovascular response and orthostatic intolerance in patients after removal of the prostate
Outcome Time Frame:
6 hours
Safety Issue:
No
Authority:
Denmark: Ethics Committee
Study ID:
RCT_PROST_ORTO
NCT ID:
NCT00771966
Start Date:
October 2008
Completion Date:
October 2009
Related Keywords:
- Prostate Cancer
- patients with cancer in the prostate
- Prostatic Neoplasms
Name | Location |
|---|
